TLDR Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.
The document discusses a case study of a 32-year-old female with Discoid lupus erythematosus (DLE), a condition that often leads to cicatricial alopecia. The patient was treated with various therapies, including injectable platelet-rich fibrin (i-PRF), which was found to be particularly effective in promoting hair regrowth. The study suggests that early and aggressive treatment in rapidly progressive DLE can potentially reverse early alopecic patches and protect hair follicles from further damage. It also proposes i-PRF as a supplementary treatment method in active DLE cases. However, the study emphasizes the need for larger and long-term trials to confirm the effectiveness of i-PRF.
23 citations,
September 2020 in “Journal of Cosmetic Dermatology” Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.
18 citations,
January 2019 in “International journal of trichology” The treatment improved hair growth in three patients with alopecia.
70 citations,
February 2015 in “Expert Opinion on Drug Discovery” Topical drugs and near-infrared light therapy show potential for treating alopecia.
11 citations,
January 2009 in “Acta Dermato Venereologica” Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.
46 citations,
March 2006 in “Seminars in Cutaneous Medicine and Surgery” Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.
1 citations,
December 2023 in “Life” PRP helps skin heal, possibly through special cells called telocytes.
31 citations,
July 2017 in “Stem cell investigation” Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.
8 citations,
October 2022 in “Regenerative Therapy” New regenerative treatments for hair loss show promise but need more research for confirmation.
36 citations,
November 2018 in “American Journal of Clinical Dermatology” Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.
February 2024 in “PloS one” Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.